Chamutal Bornstein

Chamutal Bornstein has a diverse work experience in various research and development roles. Chamutal is currently working as an Associate Principal Scientist at Immunai since June 2022. Prior to that, they served as a Research and Development team leader at ADAM Therapeutics from 2019 to 2022. Chamutal has also worked at the Weizmann Institute of Science, where they held positions as a Postdoctoral Researcher, PhD Student, and Research Assistant from 2011 to 2018. Additionally, they were an MSc student at the Weizmann Institute of Science from 2008 to 2010 and worked as a Research Assistant at Bar Ilan University from 2007 to 2008.

Chamutal Bornstein completed their Bachelor of Science (BSc) in Biotechnology from Bar-Ilan University. Chamutal then pursued a Master of Science (MSc) in Molecular Biology at the Weizmann Institute of Science. Later, Chamutal earned their Doctor of Philosophy (PhD) in Immunology genomics from the same institute.